Literature DB >> 31698322

Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors.

Eduardo R Butelman1, Carina Y Chen2, Kate G Brown2, Mary Jeanne Kreek2.   

Abstract

BACKGROUND: Persons dually diagnosed with opioid and cocaine dependence (OD + CD) present a clinical challenge and are at risk of morbidity and mortality. The time of escalation of heroin and cocaine exposure in persons with OD + CD remain understudied, and the influence of gender and other variables have not been examined. This observational study focused on the time of escalation of heroin and cocaine in volunteers with OD + CD, examining gender and exposure to other drugs (e.g., cannabis or alcohol) as predictors. Ages of first use and of onset of heaviest use of each drug were collected (in whole years). Time of escalation was defined as the interval between age of first use and onset of heaviest use. VOLUNTEERS: sequentially ascertained adult volunteers recruited from the New York Metropolitan area, of which n = 297 were diagnosed with OD + CD.
METHODS: Instruments administered were the SCID-I diagnostic interview (DSM-IV criteria), BIS-11 impulsiveness scale, and KMSK scales, dimensional measures of maximal exposure to specific drugs.
RESULTS: In volunteers with OD + CD, ages of onset of heaviest use of cannabis (median age = 15) and alcohol (median age = 19) were in adolescence or emerging adulthood and preceded those for heroin and cocaine (median ages = 26 and 25, respectively). Maximal levels of cannabis and alcohol exposure were high, in volunteers with OD + CD. In adjusted Cox regressions, gender was not a significant predictor of time of heroin or cocaine escalation. However, more rapid time of alcohol escalation was a predictor of more rapid time of escalation of both heroin and cocaine, in volunteers with OD + CD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Cannabis; Cocaine; Escalation; Exposure; Heroin

Mesh:

Year:  2019        PMID: 31698322      PMCID: PMC6893149          DOI: 10.1016/j.drugalcdep.2019.107657

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  60 in total

1.  Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration.

Authors:  Megan E Roth; Marilyn E Carroll
Journal:  Pharmacol Biochem Behav       Date:  2004-06       Impact factor: 3.533

2.  DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.

Authors:  Amie C Hayley; Con Stough; Luke A Downey
Journal:  Eur Neuropsychopharmacol       Date:  2017-06-27       Impact factor: 4.600

3.  Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids.

Authors:  Christina Marel; Matthew Sunderland; Katherine L Mills; Tim Slade; Maree Teesson; Cath Chapman
Journal:  Drug Alcohol Depend       Date:  2018-11-03       Impact factor: 4.492

4.  Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.

Authors:  Scott F Coffey; Gregory D Gudleski; Michael E Saladin; Kathleen T Brady
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

Review 5.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

6.  Development of substance abuse problems among drug-involved offenders. Evidence for the telescoping effect.

Authors:  A L Haas; R H Peters
Journal:  J Subst Abuse       Date:  2000

7.  Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Authors:  Eduardo Roque Butelman; Silvia Bacciardi; Angelo Giovanni Icro Maremmani; Maya Darst-Campbell; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Am J Addict       Date:  2017-06-27

8.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.

Authors:  Carlos A Hernandez-Avila; Bruce J Rounsaville; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

9.  Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.

Authors:  Eduardo R Butelman; Carina Y Chen; Rebecca S Fry; Rachel Kimani; Orna Levran; Jürg Ott; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2018-07-21       Impact factor: 4.492

10.  Neuropsychosocial profiles of current and future adolescent alcohol misusers.

Authors:  Robert Whelan; Richard Watts; Catherine A Orr; Robert R Althoff; Eric Artiges; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Fabiana M Carvalho; Patricia J Conrod; Herta Flor; Mira Fauth-Bühler; Vincent Frouin; Juergen Gallinat; Gabriela Gan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Jean-Luc Martinot; Frauke Nees; Nick Ortiz; Marie-Laure Paillère-Martinot; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Hugh Garavan
Journal:  Nature       Date:  2014-07-02       Impact factor: 49.962

View more
  3 in total

1.  Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.

Authors:  Eduardo R Butelman; Carina Y Chen; Kimberly J Lake; Kate G Brown; Mary Jeanne Kreek
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-29       Impact factor: 3.157

2.  Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users.

Authors:  Vadim Yuferov; Eduardo R Butelman; Matthew Randesi; Wim van den Brink; Peter Blanken; Jan M van Ree; Mary Jeanne Kreek
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-25       Impact factor: 2.570

3.  Impulsivity across substance use categories: Consideration of sex/gender.

Authors:  Elise E DeVito; Andrea H Weinberger; Raina D Pang; Nicole Petersen; Tessa Fagle; Alicia M Allen
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.